Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
Blood Advances
|
September 23, 2021
Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
Jingyu Xiang, Min Shi, Mark A Fiala, et al.
Transplantation and Cellular Therapy
|
May 22, 2022
Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality
Lawrence Wayne Liu, Alicia Yn, Feng Gao, et al.
Genome Biology
|
March 29, 2018
Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues
Dan Zhou, Bonnie M Alver, Shuang Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 22, 2009
Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts
Brett L Carlson, Patrick T Grogan, Ann C Mladek, et al.
Bone Marrow Transplantation
|
June 10, 2021
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
Yngvar Fløisand, Mark A Schroeder, Patrice Chevallier, et al.
American Journal of Hematology
|
April 12, 2014
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
John S Welch, Haixia Niu, Geoffrey L Uy, et al.
Leukemia Research
|
October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS
Eric Huselton, Michael P Rettig, Kirsten Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
Joseph M Tuscano, Emanual Maverakis, Susan Groshen, et al.
Leukemia
|
April 26, 2018
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
Jaebok Choi, Matthew L Cooper, Karl Staser, et al.
Cell Reports
|
March 15, 2016
Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins
Gaspar J Kitange, Ann C Mladek, Mark A Schroeder, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
Blood Advances
|
September 23, 2021
Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
Jingyu Xiang, Min Shi, Mark A Fiala, et al.
Transplantation and Cellular Therapy
|
May 22, 2022
Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality
Lawrence Wayne Liu, Alicia Yn, Feng Gao, et al.
Genome Biology
|
March 29, 2018
Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues
Dan Zhou, Bonnie M Alver, Shuang Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 22, 2009
Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts
Brett L Carlson, Patrick T Grogan, Ann C Mladek, et al.
Bone Marrow Transplantation
|
June 10, 2021
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
Yngvar Fløisand, Mark A Schroeder, Patrice Chevallier, et al.
American Journal of Hematology
|
April 12, 2014
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
John S Welch, Haixia Niu, Geoffrey L Uy, et al.
Leukemia Research
|
October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS
Eric Huselton, Michael P Rettig, Kirsten Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
Joseph M Tuscano, Emanual Maverakis, Susan Groshen, et al.
Leukemia
|
April 26, 2018
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
Jaebok Choi, Matthew L Cooper, Karl Staser, et al.
Cell Reports
|
March 15, 2016
Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins
Gaspar J Kitange, Ann C Mladek, Mark A Schroeder, et al.
Page
of 11